The Natural History of an Apparently Aggressive Gastric Neuroendocrine Neoplasm Type 1 Abstract #1017

Introduction: Gastric neuroendocrine neoplasm type 1 (GNEN1) is the most common GEP-NETs. GNEN1 has traditionally been considered non-metastatic as compared to the large, solitary GNEN3 that has high malignant potential.
Aim(s): To confirm that prognosis remains relatively good even in apparently aggressive GNEN1.
Materials and methods: We report the case of GNEN1 that followed an unusual initially aggressive course as it developed metastases to both lymph nodes and liver.
Conference: 11th Annual ENETS Conference 2014 (2014)
Category: Clinical cases/reports
Presenting Author: Dr Krystallenia Alexandraki
Keywords: GNEN1

To read results and conclusion, please login ...

Further abstracts you may be interested in

#1859 The Prevalence of Intestinal Metaplasia in Patients with Gastric Neuroendocrine Neoplasms Type 1
Introduction: Intestinal metaplasia (IM) of the gastric mucosa is a relatively frequent precancerous lesion.
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Epidemiology/Natural history/Prognosis - Descriptive epidemiology
Presenting Author: Georgios Boutzios
#1014 Sunitinib Induced Hypocalcaemia During Treatment of Pancreatic Neuroendocrine Tumors (pNETs)
Introduction: Sunitinib is an oral multitargeted tyrosine kinase inhibitor used for pNET treatment.
Conference: 11th Annual ENETS Conference 2014 (2014)
Category: Clinical cases/reports
Presenting Author: Krystallenia Alexandraki
#35 Primary Hyperparathyroidism in patients with gastric carcinoid Tumors type-1: an unusual coexistence
Introduction: Although a number of familiar endocrine syndromes are associated with primary hyperparathyroidism (PHP), there is no information regarding its prevalence in other sporadic neuroendocrine diseases.
Conference: 7th Annual ENETS Conference (2010)
Category: Clinical
Presenting Author: Dr Dimitrios Thomas
#478 Right Hemicolectomy in the Treatment of Patients with Appendiceal Neuroendocrine Tumors: Does Size Matter?
Introduction: A recent study of a small series of patients with appendiceal neuroendocrine tumors (ANETs) fulfilling various criteria for right hemicolectomy (RHC) revealed that approximately 25% may harbor identifiable extra-appendiceal disease. The residual disease might not have been detected using the latest European Neuroendocrine Tumors Society (ENETS) revised pathological criteria.
Conference: 9th Annual ENETS Conference (2012)
Category: Clinical
Presenting Author: Dr. Simona Grozinsky-Glasberg
#802 Metastatic Type 1 Gastric Carcinoid - A Real Threat or Just a Myth?
Introduction: Metastatic GCA1 are extremely rare and there is no data about their natural history, treatment and prognosis.
Conference: 11th Annual ENETS Conference 2014 (2014)
Category: ...none of the below
Presenting Author: Dr. Simona Glasberg